The Federal Law No. 241-FZ dated 13 July 2015 (hereinafter - the Law 241) introduced amendments to the Federal Law No. 61-FZ dated 12 April 2010 'On The Medicines Circulation' (hereinafter - the 'Circulation Law'), as well as to the Federal Law, dated 22 December 2014 No. 429-FZ (which had significantly amended the Circulation Law with the effect from 1 July 2015).

Russia's Law on the Circulation of Medicines is probably one of the country's most frequently amended laws - and certainly one of its most debated.

On July 31, 2020, Russian Federation President, Vladimir Putin, approved new amendments to the Tobacco Control Law that were initiated by Russia's Parliament.

The Federal Law № 190-FZ dated 28 June 2014 "On Amending Article 24 of the Federal Law On Advertising" which excludes from the restrictions on advertisement placement the advertisements of medical services came into force from 30June 2014.

On June 26, 2018 the Russian Federation Government adopted its Resolution No. 732 on Amendments

Governmental regulation of vital and essential medicines (hereinafter Essential Drugs) in the Russian Federation in the form in which it exists today has been functioning since 2010.

AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers.

On 1 March 2021 the Eurasian patent office (EAPO) launched a new information resource called "Pharmaceutical register" (Register).

Marketing generic drugs is an ongoing issue. The original drugs cost a large amount to create and are cheap to reproduce. Usually, generic drugs go to the market after the expiration of the relevant patent protecting...

On Dec. 25, 2014, the Russian Parliament adopted new legislation aimed at the criminalization of (1) pharmaceutical counterfeiting and (2) distribution of counterfeited and falsified medicines and medical devices.

The Eurasian Patent Organisation (EAPO) launched its Pharmaceutical Register in March 2021, and it can be accessed on the EAPO's website in Russian and partially in English

Federal State Enterprise "SHCHELKOVO BIOCOMBINAT" (SCHBK) is the largest domestic enterprise specializing in the production and supply of biotechnologies and veterinary drugs.

In what can best be described as a robust and "no bars held" move, Russia has declared that champagne producers must now include the designation "sparkling wine" on their Champagne products manufactures for export to Russia.

In early July, the international alcoholic beverage sector was alarmed by news coming from Russia regarding changes in wine and spirits legislation.

The Federal Law, dated July 31st 2020: "On Amending Certain Laws of the Russian Federation, on the Protection of Citizens' Health from the Consequences of the Consumption of ...

During 2017-2018, the Federal Antimonopoly Service of Russia ("FAS") paid close attention to advertisements of OTC medicines and considered large number cases of violations of advertising legislation by pharmaceutical companies.

On July 13, 2015 a new set of amendments to Federal Law No. 61-FZ on the Circulation of Medicines of April 12, 2010 was approved by Federal Law No. 241-FZ on Amendments to the Federal Law on the Circulation of Medicines.

The Federal Veterinary and Phytosanitation Service ("Rosselkhoznadzor") has issued Order No. 605 of June 13, 2018 (registered with the Ministry of Justice on July 20, 2018),

Foreign companies setting up sales networks in Russia should be aware of the decision summarized below, which creates a potential increased tax exposure.

On October 1, 2015, the new versions of the following regulations will come into legal force and effect: